J7401 HCPCS code: Mometasone furoate sinus implant, 10 micrograms
J7401 is the HCPCS Level II code for mometasone furoate sinus implant, 10 micrograms. CMS terminated J7401 on 2021-03-31; do not bill it for later dates of service. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2019-10-01 |
| Last action effective | 2021-04-01 |
| Terminated | 2021-03-31 |
What changed for J7401
- 2019-10-01: J7401 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J7401?
J7401 is the HCPCS Level II code for mometasone furoate sinus implant, 10 micrograms. Short descriptor: "Mometasone furoate sinus imp".
Does Medicare cover J7401?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J74 codes
- J7402 — Mometasone furoate sinus implant, (sinuva), 10 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J7401
- Watch J7401 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J7401
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.